Anabiosis Medsciences Pvt. Ltd.
Winner of India 5000 Best MSME Awards 2024
Anabiosis Medsciences Pvt. Ltd.
Winner of India 5000 Best MSME Awards 2024
Details
Anabiosis Medsciences Pvt. Ltd.
Private Limited Company
Pharmaceuticals
Manufacturer Medicinal Products for Human Consumption, Focusing on General Oral Solid Dosage Forms, Including Tablets, Capsules and Oral Liquids.
--
2017
48
Gandhinagar
Dehgam - 382315
Gujarat
Videos
Introduction
The plant holds licenses issued by The Commissioner of Food and Drug Control Administration in Gujarat, with Drug Manufacturing License No. G/25/2207 for general tablets and capsules, and G/28/1623 for liquid dosage forms. These licenses were granted in June 2022 and remain valid until June 18, 2027.
Anabiosis Medsciences underwent inspection and received approval for the WHO GMP (INDIA) Certificate on November 17, 2022, with the certificate issued on February 13, 2023, valid until February 12, 2026. The company specializes in manufacturing medicinal products for human consumption, focusing on general oral solid dosage forms, including tablets, capsules, and oral liquids.
The site has been subjected to various GMP inspections, with approvals from competent authorities in different countries. Notably, the Pharmacy and Poisons Board of Kenya has granted export validity until February 25, 2025, while the Ministry of Health in Cambodia has provided export validity until April 29, 2027.
The plant is exclusively dedicated to manufacturing the products for which it is licensed, engaging solely in the manufacturing, testing, and packing of tablets, capsules, and oral liquids, with no other activities conducted on-site.
Director Details
Mr. Dishank K. Soni
M.B.A
Mr. Dishank K. Soni is the Director of Anabiosis Medsciences Pvt. Ltd., where he has been instrumental in the company’s establishment and development since its founding. He holds an MBA with a specialization in Finance and brings over seven years of valuable experience in the pharmaceutical industry.
In his role as CEO, Mr. Soni has successfully provided strategic direction for the organization, ensuring that the company remains aligned with its goals and objectives. He has effectively implemented various changes and proposed plans to enhance operational efficiency and product quality. His collaborative approach fosters strong interaction among all managers and executives, creating an open environment for communication and innovation.
Mr. Soni also focuses on monitoring company performance, analyzing key metrics to ensure that Anabiosis Medsciences meets its targets and continues to grow in a competitive market. He emphasizes the importance of cultivating a positive working culture and environment, setting a strong precedent for his team. Under his leadership, the company remains committed to excellence in manufacturing medicinal products, upholding the highest industry standards. Mr. Soni’s vision and dedication position Anabiosis Medsciences for sustained success in the pharmaceutical sector.
